VR Logo

Natco Pharma Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1981

Chairman: V C Nannapaneni

Managing Director: V C Nannapaneni

Group: Natco

Listing: NSE: NATCOPHARM, BSE: 524816

Headquarters: Hyderabad, Telangana

Website: www.natcopharma.co.in

Key Facts

Market cap: R 16,698.29 Cr

Revenue (TTM): R 1,986.10 Cr

Earnings (TTM): R 437.40 Cr

Cash: R 94.70 Cr

Total Debt: R 315.90 Cr

Promoters' ownership: 48.91%

Liquidity: High

52 Week range: R 402.55 - 996.00

Face value: R2.00

Shares outstanding: 18,21,86,335

10 Years Aggregate:

  • CFO: 2,407.53 Cr
  • EBITDA: 4,004.34 Cr
  • Net Profit: 2,841.04 Cr

Stock Performance

Time Period Natco Pharma S&P BSE Healthcare S&P BSE Mid Cap
YTD56.4944.49-1.03
1 month-1.05-2.180.63
3 months29.3114.378.38
1 Year59.8549.112.57
3 Years-1.2411.10-3.29
5 Years12.571.406.06
10 Years32.3811.675.86
As on 28-Oct-2020
Year Natco Pharma S&P BSE Mid Cap S&P BSE Healthcare
2019-14.53-3.05-3.55
2018-29.15-13.31-5.89
201765.9148.130.49
20160.567.97-12.88
201590.607.4315.06
201488.8454.6947.43
201374.59-5.7322.55